分枝杆菌聚阿拉伯半乳糖的结构和生物合成过程及其应用意义

聚阿拉伯半乳糖(Arabinogalactan,AG)是分枝杆菌细胞壁的主要组成成分,对于维持分枝杆菌细胞壁的完整具有重要意义。AG由衔接双糖、聚阿拉伯糖及聚半乳糖组成,连接方式各异、结构复杂。AG的合成是以UDP-GlcNAc、dTDP-Rha、UDP-Galf、多聚异戊二烯磷酸阿拉伯糖(DPA)为糖基供体,其中参与糖基供体形成及AG合成的酶是研发抗结核新药的作用靶点,而由此研发出的新药对治疗结核病具有高度专一性且对人类无毒性副作用。     

分枝杆菌RpsI序列差异对核糖体结构与功能的影响

核糖体结构存在动态调控,其变化与细菌发育、环境适应等过程密切相关。使用NCBI BLAST比对结核分枝杆菌(Mycobacterium tuberculosis)核糖体蛋白RpsI、RpmI和RpmJ与耻垢分枝杆菌(Mycobacterium smegmatis)相应蛋白的氨基酸序列,发现RpsI N端氨基酸序列存在较大差异。为了探究该N端序列差异对核糖体结构与功能的影响,将表达有结核分枝杆菌rpsI基因(rpsI_Rv)的质粒整合至耻垢分枝杆菌基因组中,并利用同源重组的方法敲除耻垢分枝杆菌rpsI基因,以此构建重组菌株。聚合酶链反应(polymerase chain reaction,PCR)结果表明该重组菌株构建成功。十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)显示0.5 mmol/L异丙基-β-D-硫代半乳糖苷(IPTG)于16 ℃可诱导表达RpsI_Rv。用纯化的RpsI_Rv制备特异性多克隆抗体,其效价为 1 600 000。反转录PCR 和蛋白质印迹法(Western blot)显示rpsI_Rv在重组菌株中成功表达。测定重组菌株与空载对照菌株在不同温度下的生长曲线,该重组菌株在不同温度下的生长速率未发生改变。采用通用液体倍比稀释法测定作用于核糖体不同位点的5种抗生素最小抑菌浓度(MIC₉₀),重组菌株对阿米卡星(作用于核糖体小亚基A位点的抗生素)的敏感性升高,提示分枝杆菌RpsI序列差异导致核糖体小亚基A位点附近的结构发生改变,这为分枝杆菌核糖体结构与功能的机制研究提供了数据。     

抗结核分枝杆菌RpfB结构域单克隆抗体的制备及鉴定

目的:制备抗结核分枝杆菌Rpf B结构域单克隆抗体。方法:将p PRO-EXHT-Rpf B domain原核表达载体接种于大肠杆菌DH5中,用IPTG诱导表达Rpf B结构域蛋白,以纯化的Rpf B结构域蛋白作为免疫原,皮下包埋免疫小鼠3次,每次间隔2周;分离小鼠的脾细胞,与Sp2/0细胞融合,克隆化制备抗Rpf B结构域单抗,ELISA检测其效价,鉴定其特异性和相对亲和力,观察制备的抗Rpf B结构域单抗对Rpf家族其他蛋白的识别能力及其对结核分枝杆菌和藤黄微球菌的生长抑制作用。结果:制备了3株抗Rpf B结构域单抗,特异性高,亲和力较强,均能特异性识别Rpf B结构域。经小鼠腹腔注射制备腹水并纯化,获得了较高纯度的单抗,所制备的抗Rpf B结构域多肽的单克隆抗体可以识别多种Rpf样蛋白及其结构域蛋白。在抗体滴度为1∶1000时可有效抑制Rpf B结构域对结核分枝杆菌H37Ra和藤黄微球菌的生长促进作用,提示抗Rpf B结构域单抗可能会抑制进入机体内生长停滞或潜伏感染的结核分枝杆菌的再次激活,可能具有预防隐性感染复发的作用。结论:抗Rpf B结构域单抗的制备为进一步研究Rpf B结构域的生物学和免疫特性提供了实验工具。     

分枝杆菌制剂对小鼠细胞免疫功能影响的研究

以迟发性超敏反应与T淋巴细胞增殖反应分别作为体内,外细胞免疫功能的基本参数,探讨不同剂量的分枝杆菌,在不同时间对小鼠细胞免疫功能的影响。结果 显示免疫组的中和／或高剂量组的反应显著强于对照组（P＜0．05）,且随时间延长,剂量加大有增强的趋势。证实分枝杆菌制剂能增强机体细胞免疫功能。     

用PCR方法定向突变结核分枝杆菌glmU基因

目的:结核分枝杆茵glmU基因是分枝杆菌生长必需基因,其编码产物具有乙酰基转移酶活性和尿嘧啶转移酶活性,参与细胞壁前体物UDP-乙酰葡糖胺(UDP-GlcNAc)的生物合成,研究其空间结构可以定向设计酶抑制剂.方法:利用PCR方法定向突变结核分枝杆菌glmO基因,并用大肠杆菌BL21(DE3)高表达m-GlmU蛋白.结果:获得了定向突变的结核分枝杆菌glmU基因,m-glmU.纯化的m-GlmU蛋白仍具有乙酰基转移酶活性和尿嘧啶核苷转移酶活性.结论:纯化的m-GlmU蛋白为进一步研究其稳定性、测定其空间结构提供了物质基础.     

结核分枝杆菌Rv1009结构域基因的克隆、表达及亲和层析纯化

目的:克隆结核分枝杆菌Rv1009结构域基因,经序列测定正确后进行融合表达和纯化。方法:采用PCR从结核分枝杆菌H37Rv基因组中扩增出Rv1009结构域基因,用限制性内切酶消化后插入pUC-19克隆载体中,经测序正确后亚克隆到融合表达载体pPro-EXHT中,转化大肠杆菌DH5α,目的基因经IPTG诱导,由T7启动子调控表达了N端带6个连续组氨酸残基的Rv1009结构域多肽,在变性条件下对目的蛋白进行纯化。结果:获得了结核分枝杆菌Rv1009结构域基因,得到融合6个组氨酸残基的Rv1009结构域多肽,纯化获得的蛋白纯度大于87%。结论:构建了结核分枝杆菌Rv1009结构域基因的重组表达载体,并获得了高纯度的融合表达蛋白,为后续深入研究奠定了基础。     

结核分枝杆菌Rvl009结构域基因的克隆、表达及亲和层析纯化

目的：克隆结核分枝杆菌Rvl009结构域基因,经序列测定正确后进行融合表达和纯化。方法：采用PCR从结核分枝杆菌H37Rv基因组中扩增出Rvl009结构域基因,用限制性内切酶消化后插入pUC-19克隆载体中,经测序正确后亚克隆到融合表达载体pPro-EXHT中,转化大肠杆菌DH5α,目的基因经IPTG诱导,由T7启动子调控表达了N端带6个连续组氨酸残基的Rvl009结构域多肽,在变性条件下对目的蛋白进行纯化。结果：获得了结核分枝杆菌Rvl009结构域基因,得到融合6个组氨酸残基的Rvl009结构域多肽,纯化获得的蛋白纯度大于87％。结论：构建了结核分枝杆菌Rvl009结构域基因的重组表达载体,并获得了高纯度的融合表达蛋白,为后续深入研究奠定了基础。     

结核分枝杆菌蛋白抗原的研究进展

结核病当今世界人类致死的主要疾病之一,早期诊断发现病人、选择敏感的抗结核药物进行有效治疗是控制结核病的关键。而临床上对结核病患者检出率低,漏诊率和误诊率高,结果导致结核耐药的情况越来越严重。简便、快速、准确的免疫学检测方法在诊断结核病中起到了重要的作用。本文对用于免疫学检测的蛋白抗原作一综述。     

结核分枝杆菌中O-甘露糖基化蛋白功能的研究进展

蛋白质的O-甘露糖基化修饰不仅在真菌和哺乳类细胞中广泛存在,在原核生物中例如分枝杆菌属、棒状杆菌属和链霉菌属中也存在,尤其在引起人类疾病的结核分枝杆菌中研究最多。许多O-甘露糖基化蛋白在结核分枝杆菌毒力以及与宿主相互作用过程中发挥了重要作用。本文就结核分枝杆菌中O-甘露糖基化蛋白生物学功能的进展加以综述。     

结核分枝杆菌蛋白Rv3425对细菌表型及毒力影响的研究

为探索蛋白Rv3425在结核分枝杆菌(Mycobacterium tuberculosis,M. tuberculosis)中的功能,本研究以耻垢分枝杆菌(Mycobacterium smegmatis,M. smegmatis)为模式菌株,构建重组了耻垢分枝杆菌Ms-Rv3425。分别将构建菌株(Ms-Rv3425)、野生株(Ms)及空载对照(Ms-Pact)接种于7H9-OADC培养基中37 ℃培养,观察Ms-Rv3425与Ms及Ms-Pact之间在生长速率、菌落形态、生物膜以及聚集度方面的差异。分别用低pH值以及含有十二烷基磺酸钠(sodium dodecyl sulfate,SDS)、氨苄西林、异烟肼及利福平的培养基进行培养,计算存活率以分析抗逆和抗药能力;用上述压力条件培养结核分枝杆菌标准株H37Ra,分析Rv3425内源表达量的变化;进行THP-1细胞感染和BALB/c小鼠攻毒实验分析菌株的毒性变化。结果显示,与Ms及Ms-Pact相比,Ms-Rv3425的菌落形态更为粗糙且隆起,成膜及聚集能力增强;在压力条件下,Ms-Rv3425表现出更高的抗逆和抗药能力,H37Ra中Rv3425的表达量也显著上调;胞内存活率及小鼠致死率更高,各脏器病理损伤更为严重。综上所述,过表达Rv3425能够改变耻垢分枝杆菌的表型,提高抗逆性、抗药性和毒力。深入探讨PPE家族蛋白Rv3425的功能,将为结核病的防治带来新的视角。     

Architecture and Biosynthesis of the Saccharomyces cerevisiae Cell Wall

The wall gives a Saccharomyces cerevisiae cell its osmotic integrity; defines cell shape during budding growth, mating, sporulation, and pseudohypha formation; and presents adhesive glycoproteins to other yeast cells. The wall consists of β1,3- and β1,6-glucans, a small amount of chitin, and many different proteins that may bear N- and O-linked glycans and a glycolipid anchor. These components become cross-linked in various ways to form higher-order complexes. Wall composition and degree of cross-linking vary during growth and development and change in response to cell wall stress. This article reviews wall biogenesis in vegetative cells, covering the structure of wall components and how they are cross-linked; the biosynthesis of N- and O-linked glycans, glycosylphosphatidylinositol membrane anchors, β1,3- and β1,6-linked glucans, and chitin; the reactions that cross-link wall components; and the possible functions of enzymatic and nonenzymatic cell wall proteins.     

Arginine methylation sites on SepIVA help balance elongation and septation in Mycobacterium smegmatis

The growth of mycobacterial cells requires successful coordination between elongation and septation. However, it is not clear which factors mediate this coordination. Here, we studied the function and post-translational modification of an essential division factor, SepIVA, in Mycobacterium smegmatis. We find that SepIVA is arginine methylated, and that alteration of its methylation sites affects both septation and polar elongation of Msmeg. Furthermore, we show that SepIVA regulates the localization of MurG and that this regulation may impact polar elongation. Finally, we map SepIVA's two regulatory functions to different ends of the protein: the N-terminus regulates elongation while the C-terminus regulates division. These results establish SepIVA as a regulator of both elongation and division and characterize a physiological role for protein arginine methylation sites for the first time in mycobacteria.     

Identification of mycobacterial HSP70 reactive human T cell clones discriminating between M. tuberculosis and M. leprae

M. tuberculosis reactive CD4⁺ T cell clones were established from a BCG vaccinated donor and tested for proliferative responses against complex mycobacterial antigens like M. tuberculosis , M. leprae , and PPD, as well as the recombinant M. tuberculosis HSP70 and HSP65 antigens from both M. tuberculosis and M. leprae . This screening permitted the identification of T cell clones specifically recognizing the mycobacterial HSP70 or HSP65 antigen. All HSP65 reactive T cell clones were cross-reactive for M. tuberculosis and M. leprae , whereas three HSP70 reactive T cell clones only recognized M. tuberculosis . In addition, HLA typing and blocking experiments with anti-HLA antibodies revealed that antigen presentation to all M. tuberculosis reactive T cell clones was restricted by HLA-DR3 molecules. We have thereby demonstrated the presence of human T cell specificities directed against the mycobacterial HSP70 antigen that are able to discriminate between M. tuberculosis and M. leprae .     

Development of a Quantitative Assay for Mycobacterial Endogenous Arabinase and Ensuing Studies of Arabinase Levels and Arabinan Metabolism in Mycobacterium smegmatis

Treatment of either Mycobacterium tuberculosis or M. smegmatis with ethambutol results both in inhibition of arabinan synthesis and in copious loss of previously formed arabinan from the cell wall. The loss of arabinan has been shown to be due to the action of an endogenous arabinase. To better understand this phenomenon, a quantitative assay for endogenous arabinase was developed. Using the assay it was determined that various subcellular fractions of M. smegmatis showed significant amounts of endogenous arabinase activity. Surprisingly, treatment with ethambutol yielded only minor changes in the amounts of endogenous arabinase activities. Endogenous arabinase was present in the cell wall, and consistently, incubation of the M. smegmatis cell wall in only buffer resulted in the release of arabinan, mimicking the effect of ethambutol on whole cells. To determine if cell wall arabinan is rapidly turned over, the arabinan was labeled in the early log phase of culture by feeding [¹⁴C]glucose, followed by a “chase” with nonradioactive glucose. Most of the labeled arabinan remained in the cell wall after the culture was grown to late log phase. Thus, there is active arabinase in the cell wall, but arabinan is not rapidly removed unless ethambutol is present. Purification of the endogenous arabinase, using the assay described, is ongoing to help further discern its biological function.     

无细胞蛋白质合成系统的研究进展

无细胞蛋白质合成系统是一种以外源mRNA或DNA为模板 ,通过在细胞抽提物的酶系中补充底物和能源物质来合成蛋白质的体外系统 .与传统的体内重组表达系统相比 ,体外无细胞合成系统具有多种优点 ,如可表达对细胞有毒害作用或含有非天然氨基酸 (如D 氨基酸 )的特殊蛋白质 ,能够直接以PCR产物作为模板同时平行合成多种蛋白质 ,开展高通量药物筛选和蛋白质组学的研究等 .本文综述了无细胞蛋白质合成系统的发展历史、系统中合成蛋白质所需的能量供应、遗传模板的稳定性和微型无细胞生物反应器等多方面的研究 ,并探讨了无细胞蛋白质合成系统中存在的难点、研究方向和广泛的应用前景     

蝶呤型钼辅因子生物合成、运输及组装——潜在的药物靶标

钼辅因子作为氧化还原反应中的重要分子,参与硫、氮、碳的氧化还原代谢.钼辅因子主要分为两类:以铁硫簇为基础的铁钼辅因子和以亚钼蝶呤为基础的钼辅因子.钼-二-亚钼蝶呤-鸟苷二核苷钼辅因子(Mo-bis-MGD)是蝶呤型钼辅因子的重要成员之一,是硝酸盐还原酶的重要辅因子.膜结合硝酸盐还原酶介导的硝酸盐还原为细菌提供了氮源和能...     

The plant cell wall: Biosynthesis,construction, and functions

The plant cell wall is composed of multiple biopolymers, representing one of the most complex structural networks in nature. Hundreds of genes are involved in building such a natural masterpiece. However, the plant cell wall is the least understood cellular structure in plants. Due to great progress in plant functional genomics,manyachievementshavebeenmadein uncovering cell wall biosynthesis, assembly, and architecture, as well as cell wall regulation and signaling. Such information has significantly advanced our understanding of the roles of the cell wall in many biological and physiological processes and has enhanced our utilization of cell wall materials. The use of cutting-edge technologies such as single-molecule imaging,nuclear magnetic resonance spectroscopy, and atomic force microscopy has provided much insight into the plant cell wall as an intricate nanoscale network, opening up unprecedented possibilities for cell wall research. In this review,we summarize the major advances made in understanding the cell wall in this era of functional genomics, including the latest findings on the biosynthesis, construction, and functions of the cell wall.     

Inhibitory and Anchoring Domains in the ATPase Inhibitor Protein IF1 of Bovine Heart Mitochondrial ATP Synthase

The inhibitor protein IF1 is a basic protein of 84 residues which inhibits the ATPase activity of the mitochondrial FoF1-ATP synthase complex without having any effect on ATP synthesis. Results of cross-linking and limited proteolysis experiments are presented showing that in the intact FoF1 complex "in situ," in the inner membrane of bovine heart mitochondria, the central segment of IF1 (residues 42-58) binds to the alpha and beta subunits of F1 in a pH dependent process, and inhibits the ATPase activity. The C-terminal region of IF1 binds, simultaneously, to the OSCP subunit of Fo in a pH-independent process. This binding keeps IF1 anchored to the complex, both under inhibitory conditions, at acidic pH, and noninhibitory conditions at alkaline pH.     

Biosynthesis of galactomannans found in filamentous fungi belonging to Pezizomycotina

The galactomannans (GMs) that are produced by filamentous fungi belonging to Pezizomycotina, many of which are pathogenic for animals and plants, are polysaccharides consisting of α-(1→2)-/α-(1→6)-mannosyl and β-(1→5)-/β-(1→6)-galactofuranosyl residues. GMs are located at the outermost layer of the cell wall. When a pathogenic fungus infects a host, its cell surface must be in contact with the host. The GMs on the cell surface may be involved in the infection mechanism of a pathogenic fungus or the defense mechanism of a host. There are two types of GMs in filamentous fungi, fungal-type galactomannans and O-mannose type galactomannans. Recent biochemical and genetic advances have facilitated a better understanding of the biosynthesis of both types. This review summarizes our current information on their biosynthesis.     

Anchoring skeletal muscle development and disease: the role of ankyrin repeat domain containing proteins in muscle physiology

The ankyrin repeat is a protein module with high affinity for other ankyrin repeats based on strong Van der Waals forces. The resulting dimerization is unusually resistant to both mechanical forces and alkanization, making this module exceedingly useful for meeting the extraordinary demands of muscle physiology. Many aspects of muscle function are controlled by the superfamily ankyrin repeat domain containing proteins, including structural fixation of the contractile apparatus to the muscle membrane by ankyrins, the archetypical member of the family. Additionally, other ankyrin repeat domain containing proteins critically control the various differentiation steps during muscle development, with Notch and developmental stage-specific expression of the members of the Ankyrin repeat and SOCS box (ASB) containing family of proteins controlling compartment size and guiding the various steps of muscle specification. Also, adaptive responses in fully formed muscle require ankyrin repeat containing proteins, with Myotrophin/V-1 ankyrin repeat containing proteins controlling the induction of hypertrophic responses following excessive mechanical load, and muscle ankyrin repeat proteins (MARPs) acting as protective mechanisms of last resort following extreme demands on muscle tissue. Knowledge on mechanisms governing the ordered expression of the various members of superfamily of ankyrin repeat domain containing proteins may prove exceedingly useful for developing novel rational therapy for cardiac disease and muscle dystrophies.